PAPER Muroni A, Floris G, Borghero G, Ardu S, Pateri MI, Pilotto S, Pisano G, Defazio G

Point prevalence of epilepsy in dementia: A "real-world" estimate.

Epileptic Disord. 2024 Apr;26(2):209-214. Epub 2024 Mar 13 PubMed.

PAPER Mansuri S, Jain A, Singh R, Rawat S, Mondal D, Raychaudhuri S

Widespread nuclear lamina injuries defeat proteostatic purposes of α-synuclein amyloid inclusions.

J Cell Sci. 2024 Apr 1;137(7) Epub 2024 Apr 16 PubMed.

PAPER Biesbroek JM, Coenen M, DeCarli C, Fletcher EM, Maillard PM, Alzheimer's Disease Neuroimaging Initiative, Barkhof F, Barnes J, Benke T, Chen CP, Dal-Bianco P, Dewenter A, Duering M, Enzinger C, Ewers M, Exalto LG, Franzmeier N, Hilal S, Hofer E, Koek HL, Maier AB, McCreary CR, Papma JM, Paterson RW, Pijnenburg YA, Rubinski A, Schmidt R, Schott JM, Slattery CF, Smith EE, Sudre CH, Steketee RM, Teunissen CE, van den Berg E, van der Flier WM, Venketasubramanian N, Venkatraghavan V, Vernooij MW, Wolters FJ, Xin X, Kuijf HJ, Biessels GJ

Amyloid pathology and vascular risk are associated with distinct patterns of cerebral white matter hyperintensities: A multicenter study in 3132 memory clinic patients.

Alzheimers Dement. 2024 Apr;20(4):2980-2989. Epub 2024 Mar 13 PubMed.

PAPER Howard R, Cort E, Rawlinson C, Wiegand M, Downey A, Lawrence V, Banerjee S, Bentham P, Fox C, Harwood R, Hunter R, Livingston G, Moniz-Cook E, Panca M, Raczek M, Ivenso C, Russell G, Thomas A, Wilkinson P, Freemantle N, Gould R

Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trial.

Alzheimers Dement. 2024 Apr;20(4):2990-2999. Epub 2024 Mar 13 PubMed.

PAPER Mekkes NJ, Groot M, Hoekstra E, de Boer A, Dagkesamanskaia E, Bouwman S, Wehrens SM, Herbert MK, Wever DD, Rozemuller A, Eggen BJ, Huitinga I, Holtman IR

Identification of clinical disease trajectories in neurodegenerative disorders with natural language processing.

Nat Med. 2024 Apr;30(4):1143-1153. Epub 2024 Mar 12 PubMed.

PAPER Tolar M, Hey JA, Power A, Abushakra S

The Single Toxin Origin of Alzheimer's Disease and Other Neurodegenerative Disorders Enables Targeted Approach to Treatment and Prevention.

Int J Mol Sci. 2024 Feb 27;25(5) PubMed.

PAPER Zheng Z, Zhang S, Liu X, Wang X, Xue C, Wu X, Zhang X, Xu X, Liu Z, Yao L, Lu G

LRRK2 regulates ferroptosis through the system Xc-GSH-GPX4 pathway in the neuroinflammatory mechanism of Parkinson's disease.

J Cell Physiol. 2024 May;239(5):e31250. Epub 2024 Mar 13 PubMed.

PAPER Pappalettera C, Carrarini C, Miraglia F, Vecchio F, Rossini PM

Cognitive resilience/reserve: Myth or reality? A review of definitions and measurement methods.

Alzheimers Dement. 2024 May;20(5):3567-3586. Epub 2024 Mar 13 PubMed.

PAPER Chiu SY, Chen R, Wang WE, Armstrong MJ, Boeve BF, Savica R, Ramanan V, Fields JA, Graff-Radford N, Ferman TJ, Kantarci K, Vaillancourt DE, Alzheimer's Disease Neuroimaging Initiative

Longitudinal Free-Water Changes in Dementia with Lewy Bodies.

Mov Disord. 2024 May;39(5):836-846. Epub 2024 Mar 13 PubMed.

PAPER Hattori N, Funayama M, Imai Y, Hatano T

Pathogenesis of Parkinson's disease: from hints from monogenic familial PD to biomarkers.

J Neural Transm (Vienna). 2024 Jun;131(6):709-719. Epub 2024 Mar 13 PubMed.

PAPER Kamal F, Morrison C, Dadar M

Investigating the relationship between sleep disturbances and white matter hyperintensities in older adults on the Alzheimer's disease spectrum.

Alzheimers Dement (Amst). 2024;16(1):e12553. Epub 2024 Mar 11 PubMed.

PAPER Kim Y, Cho M, Jang CH, Lee JS, Kim JS, Oh J, Lim J

Oral Administration of Euonymus alatus Leaf Extract Ameliorates Alzheimer's Disease Phenotypes in 5xFAD Transgenic Mice.

Foods. 2024 Feb 23;13(5) PubMed.

PAPER Ruwanpathirana GP, Williams RC, Masters CL, Rowe CC, Johnston LA, Davey CE

Inter-scanner Aβ-PET harmonization using barrel phantom spatial resolution matching.

Alzheimers Dement (Amst). 2024;16(1):e12561. Epub 2024 Mar 11 PubMed.

PAPER Paulsen AJ, Pinto AA, Schubert CR, Chappell RJ, Chen Y, Engelman CD, Ferrucci L, Hancock LM, Johnson SC, Merten N

Midlife sensory and motor functions improve prediction of blood-based measures of neurodegeneration and Alzheimer's disease in late middle-age.

Alzheimers Dement (Amst). 2024;16(1):e12564. Epub 2024 Mar 11 PubMed.

PAPER Nuber S, Zhang X, McCaffery TD, Moors TE, Adom MA, Hahn WN, Martin D, Ericsson M, Tripathi A, Dettmer U, Svenningsson P, Selkoe DJ

Author Correction: Generation of G51D and 3D mice reveals decreased α-synuclein tetramer-monomer ratios promote Parkinson's disease phenotypes.

NPJ Parkinsons Dis. 2024 Mar 12;10(1):57. PubMed.